REPORTS

Let’s Pullulate and Expand Your Business

Breast Cancer Liquid Biopsy Market - Global Professional Analysis and Forecast to 2026

Feb 28, 2020  |  205 PAGES  |  REPORT CODE: CMM269088
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Breast Cancer Liquid Biopsy market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 13.7% during the forecast period.

This report presents the market size and development trends by detailing the Breast Cancer Liquid Biopsy market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Breast Cancer Liquid Biopsy market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Breast Cancer Liquid Biopsy industry and will help you to build a panoramic view of the industrial development.

Breast Cancer Liquid Biopsy Market, By Type:

  • Circulating Tumor Cells (CTCs)

  • Cell-Free DNA (CfDNA)

  • Extracellular Vesicles (EVs)

  • Other Circulating Biomarkers

Breast Cancer Liquid Biopsy Market, By Application:

  • Hospitals

  • Diagnostic Centers

  • Laboratories

Some of the leading players are as follows:

  • RainDance Technologies

  • Menarini Silicon Biosystems

  • Bio-Rad Laboratories

  • Roche Diagnostics

  • Thermo Fisher Scientific

  • Illumina

  • Biocept

  • Trovagene

  • Guardant Health

  • QIAGEN

  • Genomic Health

  • MDx Health

  • Myriad Genetics

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Breast Cancer Liquid Biopsy Market: Technology Type Analysis

  • 4.1 Breast Cancer Liquid Biopsy Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Breast Cancer Liquid Biopsy Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Circulating Tumor Cells (CTCs)

    • 4.3.2 Cell-Free DNA (CfDNA)

    • 4.3.3 Extracellular Vesicles (EVs)

    • 4.3.4 Other Circulating Biomarkers

5 Breast Cancer Liquid Biopsy Market: Product Analysis

  • 5.1 Breast Cancer Liquid Biopsy Product Market Share Analysis, 2018 & 2026

  • 5.2 Breast Cancer Liquid Biopsy Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Breast Cancer Liquid Biopsy Market: Application Analysis

  • 6.1 Breast Cancer Liquid Biopsy Application Market Share Analysis, 2018 & 2026

  • 6.2 Breast Cancer Liquid Biopsy Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Hospitals

    • 6.3.2 Diagnostic Centers

    • 6.3.3 Laboratories

7 Breast Cancer Liquid Biopsy Market: Regional Analysis

  • 7.1 Breast Cancer Liquid Biopsy Regional Market Share Analysis, 2018 & 2026

  • 7.2 Breast Cancer Liquid Biopsy Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 RainDance Technologies

    • 9.1.1 RainDance Technologies Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Menarini Silicon Biosystems

    • 9.2.1 Menarini Silicon Biosystems Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Bio-Rad Laboratories

    • 9.3.1 Bio-Rad Laboratories Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Roche Diagnostics

    • 9.4.1 Roche Diagnostics Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Thermo Fisher Scientific

    • 9.5.1 Thermo Fisher Scientific Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Illumina

    • 9.6.1 Illumina Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Biocept

    • 9.7.1 Biocept Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Trovagene

    • 9.8.1 Trovagene Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Guardant Health

    • 9.9.1 Guardant Health Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 QIAGEN

    • 9.10.1 QIAGEN Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Genomic Health

    • 9.11.1 Genomic Health Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 MDx Health

    • 9.12.1 MDx Health Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 Myriad Genetics

    • 9.13.1 Myriad Genetics Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

 

The List of Tables and Figures (Totals 106 Figures and 141 Tables)

  • Figure Circulating Tumor Cells (CTCs) Breast Cancer Liquid Biopsy market, 2015 - 2026 (USD Million)

  • Figure Cell-Free DNA (CfDNA) Breast Cancer Liquid Biopsy market, 2015 - 2026 (USD Million)

  • Figure Extracellular Vesicles (EVs) Breast Cancer Liquid Biopsy market, 2015 - 2026 (USD Million)

  • Figure Other Circulating Biomarkers Breast Cancer Liquid Biopsy market, 2015 - 2026 (USD Million)

  • Figure Hospitals market, 2015 - 2026 (USD Million)

  • Figure Diagnostic Centers market, 2015 - 2026 (USD Million)

  • Figure Laboratories market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Breast Cancer Liquid Biopsy market, by country, 2015 - 2026 (USD Million)

  • Table North America Breast Cancer Liquid Biopsy market, by type, 2015 - 2026 (USD Million)

  • Table North America Breast Cancer Liquid Biopsy market, by product, 2015 - 2026 (USD Million)

  • Table North America Breast Cancer Liquid Biopsy market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Breast Cancer Liquid Biopsy market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Breast Cancer Liquid Biopsy market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Breast Cancer Liquid Biopsy market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Breast Cancer Liquid Biopsy market, by type, 2015 - 2026 (USD Million)

  • Table Canada Breast Cancer Liquid Biopsy market, by product, 2015 - 2026 (USD Million)

  • Table Canada Breast Cancer Liquid Biopsy market, by application, 2015 - 2026 (USD Million)

  • Table Europe Breast Cancer Liquid Biopsy market, by country, 2015 - 2026 (USD Million)

  • Table Europe Breast Cancer Liquid Biopsy market, by type, 2015 - 2026 (USD Million)

  • Table Europe Breast Cancer Liquid Biopsy market, by product, 2015 - 2026 (USD Million)

  • Table Europe Breast Cancer Liquid Biopsy market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Breast Cancer Liquid Biopsy market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Breast Cancer Liquid Biopsy market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Breast Cancer Liquid Biopsy market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Breast Cancer Liquid Biopsy market, by type, 2015 - 2026 (USD Million)

  • Table Germany Breast Cancer Liquid Biopsy market, by product, 2015 - 2026 (USD Million)

  • Table Germany Breast Cancer Liquid Biopsy market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Breast Cancer Liquid Biopsy market, by type, 2015 - 2026 (USD Million)

  • Table France Breast Cancer Liquid Biopsy market, by product, 2015 - 2026 (USD Million)

  • Table France Breast Cancer Liquid Biopsy market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Breast Cancer Liquid Biopsy market, by type, 2015 - 2026 (USD Million)

  • Table Italy Breast Cancer Liquid Biopsy market, by product, 2015 - 2026 (USD Million)

  • Table Italy Breast Cancer Liquid Biopsy market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Breast Cancer Liquid Biopsy market, by type, 2015 - 2026 (USD Million)

  • Table Spain Breast Cancer Liquid Biopsy market, by product, 2015 - 2026 (USD Million)

  • Table Spain Breast Cancer Liquid Biopsy market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Breast Cancer Liquid Biopsy market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Breast Cancer Liquid Biopsy market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Breast Cancer Liquid Biopsy market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Breast Cancer Liquid Biopsy market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Breast Cancer Liquid Biopsy market, by type, 2015 - 2026 (USD Million)

  • Table China Breast Cancer Liquid Biopsy market, by product, 2015 - 2026 (USD Million)

  • Table China Breast Cancer Liquid Biopsy market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Breast Cancer Liquid Biopsy market, by type, 2015 - 2026 (USD Million)

  • Table Japan Breast Cancer Liquid Biopsy market, by product, 2015 - 2026 (USD Million)

  • Table Japan Breast Cancer Liquid Biopsy market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Breast Cancer Liquid Biopsy market, by type, 2015 - 2026 (USD Million)

  • Table India Breast Cancer Liquid Biopsy market, by product, 2015 - 2026 (USD Million)

  • Table India Breast Cancer Liquid Biopsy market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Breast Cancer Liquid Biopsy market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Breast Cancer Liquid Biopsy market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Breast Cancer Liquid Biopsy market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Breast Cancer Liquid Biopsy market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Breast Cancer Liquid Biopsy market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Breast Cancer Liquid Biopsy market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Breast Cancer Liquid Biopsy market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Breast Cancer Liquid Biopsy market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Breast Cancer Liquid Biopsy market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Breast Cancer Liquid Biopsy market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Breast Cancer Liquid Biopsy market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Breast Cancer Liquid Biopsy market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Breast Cancer Liquid Biopsy market, by application, 2015 - 2026 (USD Million)

  • Table MEA Breast Cancer Liquid Biopsy market, by country, 2015 - 2026 (USD Million)

  • Table MEA Breast Cancer Liquid Biopsy market, by type, 2015 - 2026 (USD Million)

  • Table MEA Breast Cancer Liquid Biopsy market, by product, 2015 - 2026 (USD Million)

  • Table MEA Breast Cancer Liquid Biopsy market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Breast Cancer Liquid Biopsy market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Breast Cancer Liquid Biopsy market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Breast Cancer Liquid Biopsy market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Breast Cancer Liquid Biopsy market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Breast Cancer Liquid Biopsy market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Breast Cancer Liquid Biopsy market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table RainDance Technologies Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Menarini Silicon Biosystems Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bio-Rad Laboratories Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Roche Diagnostics Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Thermo Fisher Scientific Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Illumina Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Biocept Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Trovagene Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Guardant Health Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table QIAGEN Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Genomic Health Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table MDx Health Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Myriad Genetics Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top